Atlas Trials

Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Clinical trial NCT01437449 · COMPLETED

Trial details

NCT number
NCT01437449
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2011-10-01
Primary completion
2018-09-11
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.